J v /A = L p { (P c - P i ) σ (π p - π i ) } 7/13/14. Current Concepts and Controversies in Small Animal Critical Care. Goals and Objec.

Similar documents
What is the right fluid to use?

Fluid Management in the Critically-Ill

What is the Role of Albumin in Sepsis? An Evidenced Based Affair. Justin Belsky MD PGY3 2/6/14

Intravenous Fluid Therapy in Critical Illness

Fluid resuscitation in specific patient populations: sepsis and traumatic brain injury

Modern fluid therapy. Anders Perner. Dept of Intensive Care, Rigshospitalet, University of Copenhagen

Fluids in ICU. JMO teaching 5th July 2016

Les solutés de remplissage. Philippe Van der Linden MD, PhD

Actualités sur le remplissage peropératoire. Philippe Van der Linden MD, PhD

Comment on infusion solutions containing HES

Fluid Treatments in Sepsis: Meta-Analyses

Practical fluid therapy in companion animals part 1

Resuscitation fluids in critical care

Fluid management of Neurosurgical patient, Recent update

FLUID RESUSCITATION SUMMARY

What works in sepsis. Topics. EGDT: Severe Sepsis/ Shock. Sepsis

Fluid Therapy and Outcome: Balance Is Best

Maria B. ALBUJA-CRUZ, MD ALBUMIN: OVERRATED. Surgical Grand Rounds

Albumin: rationale, use and evidence

Hydroxyethyl starch and bleeding

Presented by: Indah Dwi Pratiwi

Getting smart with fluids in the critically ill. NOR AZIM MOHD YUNOS Jeffrey Cheah School of Medicine & Health Sciences Monash University Malaysia

The ins and outs of fluid therapy: crystalloids versus colloids

JOURNAL CLUB: THE FLUIDS DEBATE. Veronica Ueckermann

Collec&ng Ducts. Types of Nephrons

Managing Patients with Sepsis

John Park, MD Assistant Professor of Medicine

Fluids in Sepsis: How much and what type? John Fowler, MD, FACEP Kent Hospital, İzmir Eisenhower Medical Center, USA American Hospital Dubai, UAE

Principles of Fluid Balance

Update in Critical Care Medicine

FLUIDS AND SOLUTIONS IN THE CRITICALLY ILL. Daniel De Backer Department of Intensive Care Erasme University Hospital Brussels, Belgium

Albumin Regulation and Reimbursement

How and why I give IV fluid Disclosures SCA Fluids and public health 4/1/15. Andrew Shaw MB FRCA FCCM FFICM

Albumina nel paziente critico. Savona 18 aprile 2007

Principles of Infusion Therapy: Fluids

IV fluid administration in sepsis. Dr David Inwald Consultant in PICU St Mary s Hospital, London CATS, London

Fluids in Sepsis Less is more. Dr Anand Senthi Joondalup Health Campus ED MBBS, MAppFin, GradCertPubHlth,

Enjoy!!! Course finals!!! Practice the national standard skills performance criteria for pre-hospital emergency providers

Proceeding of the LAVECCS

Context-sensitive fluid therapy in critical illness

What Fluid? Tim Harris Prof emergency Medicine

Septic AKI in ICU patients

Sepsis Management: Past, Present, and Future

Reverse (fluid) resuscitation Should we be doing it? NAHLA IRTIZA ISMAIL

Fluids Watch the type and measure the quantity

Dr. Nai Shun Tsoi Department of Paediatric and Adolescent Medicine Queen Mary Hospital Hong Kong SAR

Sepsis and Multiple Organ Failure. J.G. van der Hoeven Radboud University Nijmegen Medical Centre

Rq : Serum = plasma w/ fibrinogen and other other proteins involved in clotting removed.

Salt of the earth or a drop in the ocean An overview of the properties of iv fluids

METHODS RESULTS. Int. J. Med. Sci. 2012, 9. Methods of measurement. Outcome measures. Primary data analysis. Study design and setting

Fluid assessment, monitoring and therapy for the acute nurse

Fluid Therapy in Critical Illness

Acqua e sale. Aghe (ago) e saal

Back to the Future: Updated Guidelines for Evaluation and Management of Adrenal Insufficiency in the Critically Ill

IV Fluids. I.V. Fluid Osmolarity Composition 0.9% NaCL (Normal Saline Solution, NSS) Uses/Clinical Considerations

Sepsis Management Update 2014

Current issues in Volume therapy

Objectives. Epidemiology of Sepsis. Review Guidelines for Resuscitation. Tx: EGDT, timing/choice of abx, activated

INTRAVENOUS FLUID THERAPY. Tom Heaps Consultant Acute Physician

ROBERT SÜMPELMANN MD, PhD*, LARS WITT MD*, MEIKE BRÜTT MD*, DIRK OSTERKORN MD, WOLFGANG KOPPERT MD, PhD* AND WILHELM A.

"Small Volume" Resuscitation for Trauma Cases : PRO Aspects

Fluid resuscitation with colloid and crystalloid solutions is a

12/29/2014. IV/IO Therapy & Fluid Administration. Objectives. Cleansing of the soul

FLUID THERAPY: IT S MORE THAN JUST LACTATED RINGERS

Safety of 6% hydroxyethylstarch 130/0.42 in term neonates with severe HIE

Salty Solutions or Salty Problems? Outline. Outline 29/04/2013

I Suggest Abnormal Saline

Microcirculation and Edema. Faisal I. Mohammed MD, PhD.

MOVING IN AND PREVENTING THE KILL Elke Rudloff, DVM, DACVECC

Time is Muscle. In this talk, I will address 3 ques7ons: School of Rehabilita?on Science Reaching Further

WHAT S NEW-ISH IN ARDS MANAGEMENT AFTER TRAUMA?

Fluids and Lactate. A/Prof Peter Morley

Out Line OF Lecture. Dr S Manimala Rao

HYPOVOLEMIA AND HEMORRHAGE UPDATE ON VOLUME RESUSCITATION HEMORRHAGE AND HYPOVOLEMIA DISTRIBUTION OF BODY FLUIDS 11/7/2015

Filtration and Reabsorption Amount Filter/d

RESUSCITATION IN TRAUMA. Important things I have learnt

Critical Care Medicine Update for Non-Intensivists 2015

Fluid and electrolyte therapies including nutritional support are markedly developing in medicine

Fundamentals of Pharmacology for Veterinary Technicians Chapter 19

Dr. Carlos Fernando Estrada Garzona. Departamento de Farmacología Universidad de Costa Rica

Microcirculation and Edema- L1 L2

Stroke in Human Immunodeficiency Virus (HIV) infected pa9ents

Intraoperative Fluid Management. David G Hovord BA MB BChir FRCA Clinical Assistant Professor University of Michigan

Evidence-Based. Management of Severe Sepsis. What is the BP Target?

Vasopressors for shock

A protocol for the 0.9% saline versus Plasma-Lyte 148 for intensive care fluid therapy (SPLIT) study

Renal Quiz - June 22, 21001

Nothing to disclose 9/25/2017

KASHVET VETERINARIAN RESOURCES FLUID THERAPY AND SELECTION OF FLUIDS

Fluid Resuscitation in Sepsis. A Literature Review

Crystalloid infusion rate during fluid resuscitation from acute haemorrhage

9/25/2017. Nothing to disclose

PRACTICE. Intravenous fluid therapy in adult inpatients COMPETENT NOVICE. Fluid balance in disease and injury. How best to do it. Normal fluid balance

Choice of fluid in acute illness: what should be given? An international consensus

Managing Acid Base and Electrolyte Disturbances with RRT

Intravenous fluid selection rationales in acute clinical management

Volume Replacement in Dengue Shock Syndrome

Kristan Staudenmayer, MD Stanford University, Stanford, CA

THe Story of salty Sam

A multicentre, randomised controlled pilot study of fluid resuscitation with saline or Plasma-Lyte 148 in critically ill patients

Transcription:

The Crystalloid vs. Colloid Controversy Continues Karl E. Jandrey, DVM, MAS, DAVCECC Associate Professor of Clinical Small Animal Emergency & Critical Care 2 nd Annual Conti Symposium, UC Irvine August 3, 2014 Current Concepts and Controversies in Small Animal Critical Care Goals and Objec.ves Fluid Physiology and Behavior Review & New Understandings Crystalloids & Colloids in the ICU Evidence from human studies Decision- making The Challenge J v /A = L p { (P c - P i ) σ (π p - π i ) } J v = Volume filtra.on rate A = Endothelial area L p = Coefficient of fitra.on P = Hydrosta.c pressure π = Osmo.c pressure σ = Osmo.c reflec.on coefficient 1

J v /A = L p { (P c - P i ) σ (π p - π i ) } J v = Volume filtra.on rate A = Endothelial area Difference Extravascular fluid between L p flux: = Coefficient fluid capillary of fitra.on blood movement across pressure and P semipermeable = Hydrosta.c Inters..al membranes hydrosta.c π = Osmo.c pressure σ = Osmo.c reflec.on coefficient Difference between plasma and inters..al osmo.c pressure J v /A = L p { (P c - P i ) σ (π p - π i ) } Pi σ π i π p J v /A Starling Principle: Classic Model Levick and Michel, Cardio Res 2010,87:198-210. 2

7/13/14 Starling Principle: Revised Model Glycocalyx Model Levick and Michel, Cardio Res 2010,87:198-210. Myburgh & Mythen, NEJM 2013,369(13):1243-1251. 3

Capillaries are not Created Equally Woodcock, Br J Anesth 2012,108(3):384-394. J v /A σ Inters..al Intracellular Intravascular J v /A σ Plasma Inters..al Intracellular 4

Original Starling Principle IV volume = plasma and cells Capillaries separate plasma [high protein] from inters..al [low protein] spaces Revised Starling + Glycocalyx Model IV volume = glycocalyx + plasma + RBCs Inters..al and plasma volumes communicate directly where there are discon.nuous capillaries. Open fenestrated capillaries produce glomerular filtrate. EGL is semipermeable to anionic proteins and their concentra.on in the cled is low. Con.nuous capillaries exhibit no absorp.on Important force is between transendothelial pressure and plasma- inters..al COP difference. Fluid is filtered from the arterial end of the capillary and reabsorbed at the venous end. Lymph return is small. Important force is transendothelial pressuredifference and plasma- subglycocalyx COP difference. Jv is much less than predicted and the major route for return of fluid to the circula.on is as lymph. Original Starling Principle Raising plasma COP enhances absorp.on and shids fluid from inters..um to plasma. At subnormal capillary pressure, net absorp.on increases plasma volume. At supranormal capillary pressure, net filtra.on increases inters..al volume. Infused colloid solu.on is distributed through the plasma volume, and infused isotonic salt solu.ons through the extracellular volume. Revised Starling + Glycocalyx Model Raising plasma COP reduces Jv but does not cause reabsorp.on. At subnormal capillary pressure, Jv approaches zero. Autotransfusion is acute, transient, and limited ~(500ml in humans). At supranormal capillary pressure, when the COP difference in maximal, Jv is propor.onal to transendothelial pressure difference. Infused colloid solu.on is ini#ally distributed through the plasma volume and infused isotonic salt solu.ons through the intravascular volume. At supranormal capillary pressure, infused colloid solu.on preserves COP, raises capillary pressure, and increases Jv. At supranormal capillary pressure, infused isotonic salt solu.on also raises capillary pressure, but it lowers COP and thus increases Jv (more than the same volume of colloid). Adapted from Woodcock, BJA 2012,108(3):384-394. What do we know now Classic Starling Revised Starling and Glycocalyx model How this new concept helps us to understand fluid therapy and the pa.ent response 5

Colloids vs. Crystalloid Recent Randomized Human Trails SAFE study Albumin vs. 0.9% NaCl CHEST study HES in 0.9% NaCl vs. 0.9% NaCl 6S HES in Ringer s acetate vs. Ringer s acetate CRISTAL Crystalloids vs. colloids in hypovolemic shock The Saline vs. Albumin Fluid Evalua.on Study Finfer et al,nejm 2004,350(22):2247-2256. The Saline vs. Albumin Fluid Evalua.on Study Blinded, randomized controlled trial 6997 adults in 18 ICUs 4% albumin (3497) vs. 0.9% NaCl (3500) Outcome measure: death at 28 days Results: no difference in death rate development of new organ failure LOS, mechanical ven.la.on, RRT Finfer et al,nejm 2004,350(22):2247-2256. 6

The Saline vs. Albumin Fluid Evalua.on Study Finfer et al,nejm 2004,350(22):2247-2256. The Saline vs. Albumin Fluid Evalua.on Study Finfer et al,nejm 2004,350(22):2247-2256. Crystalloid vs. Hydroxyethyl Starch Trial Myburgh et al,nejm 2012,367(20):1901-1911. 7

Crystalloid vs. Hydroxyethyl Starch Trial Blinded, randomized controlled trial 7000 adults in 32 ICUs 6% HES (130/0.4) vs. 0.9% NaCl Outcome measure: death at 90 days Results: no difference in death rate (6 predefined subgroups) HES Tx à need for RRT Myburgh et al,nejm 2012,367(20):1901-1911. Crystalloid vs. Hydroxyethyl Starch Trial Myburgh et al,nejm 2012,367(20):1901-1911. Crystalloid vs. Hydroxyethyl Starch Trial Myburgh et al,nejm 2012,367(20):1901-1911. 8

Crystalloid vs. Hydroxyethyl Starch Trial Myburgh et al,nejm 2012,367(20):1901-1911. Crystalloid vs. Hydroxyethyl Starch Trial Myburgh et al,nejm 2012,367(20):1901-1911. Scandanavian Starch for Severe Sepsis/Sep.c Shock (6S) Trial Perner et al, NEJM 2012,367(2):124-134. 9

Scandanavian Starch for Severe Sepsis/Sep.c Shock (6S) Trial Blinded, randomized controlled trial 800 adults ICUs 6% HES (130/0.42) vs. Ringer s acetate Outcome measure: death at 90 days Results: 1.17 increase in rate of death with HES HES Tx à 35% rela.ve increase in RRT Similar to 10% HES (200/0.5) in another trial Perner et al, NEJM 2012,367(2):124-134. Scandanavian Starch for Severe Sepsis/Sep.c Shock (6S) Trial Perner et al, NEJM 2012,367(2):124-134. Scandanavian Starch for Severe Sepsis/Sep.c Shock (6S) Trial Perner et al, NEJM 2012,367(2):124-134. 10

CHEST and 6S No significant difference in short- term hemodynamic endpoints HES:crystalloid ~1:1.3 Similar to SAFE and other trials Cochrane Review 2013 Colloids vs. crystalloids for fluid resuscita.on in cri.cally ill pa.ents (Perel et al) There is no evidence from randomized controlled trials that resuscita.on with colloids reduces the risk of death, comparede to resuscita.on with crystalloids, in pa.ents with trauma, burns, or following surgery. Furthermore, the use of hydroxyethyl starch might increase mortality. Colloids vs. crystalloids for the Resuscita.on of the Cri.cally Ill (CRISTAL) Trial Annane et al, JAMA 2013,310(17):1809-1817. 11

CRISTAL Trial Open label, randomized controlled trial 2857 adults in 57 interna.onal ICUs Mul.ple colloids vs. mul.ple crystalloids Outcome measure: death at 28 days Results: No difference in 28 day mortality Colloids favored at 90 day mortality Annane et al, JAMA 2013,310(17):1809-1817. CRISTAL Trial Annane et al, JAMA 2013,310(17):1809-1817. CRISTAL Trial Annane et al, JAMA 2013,310(17):1809-1817. 12

What is it about 0.9% NaCl? Most commonly used crystalloid worldwide Strong ion difference is zero Results in hyperchloremic metabolic acidosis Worries about renal and immune func.ons Is a balanced crystalloid bezer? Is there a difference amongst crystalloids? Raghunathan et al,ccm 2014,42(7):1585-1591. 13

Is there a difference amongst crystalloids? Retrospec.ve cohort of sep.c pa.ents 360 US ICUs 53,448 adults Stra.fied based on fluids received Outcome measure: hospital mortality > day 2 Raghunathan et al,ccm 2014,42(7):1585-1591. Is there a difference amongst crystalloids? Raghunathan et al,ccm 2014,42(7):1585-1591. What does the future hold? A Comparison of High and Low Chloride Containing IV Fluid Solu.ons in Pa.ents Undergoing Major Surgery and/or ICU Admission Expected 3000 adults, Mortality at 7 days Secondary: LOS, renal failure, dysrhythmias, infec.on, electrolyte disorders. 14

And an experimental canine study Gauthier et al, JVECC 2014,24(3):251-258. Crystalloids vs. colloids, canine SIRS Randomized, placebo- controlled, blinded 16 Beagles, cross- over 40ml/kg 0.9% NaCl vs. tetrastarch (130/0.4) Gauthier et al, JVECC 2014,24(3):251-258. Crystalloids vs. colloids, canine SIRS Similar changes in hemodynamics and lab values in dogs with LPS- induced inflamma.on Tetrastarch produced larger increase in heart rate and blood pressure in first 2 hours No long term follow- up Renal parameters not measured Gauthier et al, JVECC 2014,24(3):251-258. 15

Future Direc.ons Use human studies to help understand our pa.ents fluid needs for cri.cal illness Remember that human studies use 0.9% NaCl far more oden than balanced solu.ons. Veterinary clinical prac.ce may not exactly reflect these tradi.ons/studies. There is no perfect fluid choice for all disease states. 16